25 participants
Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-04-20
- Start Date:
- 2011-04-30
- Completion:
- 2014-01-31
Conditions
- Chronic Graft-versus-host Disease
Interventions
- DRUG